Stock Events

Stock Events

LakeShore Biopharma 

$0.067000
0
+$0.00+0% Wednesday 20:00

Statistics

Day High
0.07
Day Low
0.07
52W High
1.48
52W Low
0.0278
Volume
3
Avg. Volume
3,995
Mkt Cap
1.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

17AprExpected
Q4 0
Q4 2025
Q1 2026
-0.17
0.17
0.5
0.83
Expected EPS
N/A
Actual EPS
N/A

Financials

-75.59%Profit Margin
Unprofitable
2020
2021
2022
2023
158.59MRevenue
-119.88MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap31.65B
Moderna, Inc. competes in the biotechnology and pharmaceuticals space, focusing on mRNA-based therapies, similar to YS Biopharma's focus on innovative biopharmaceuticals.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech SE operates in the field of mRNA technology for developing vaccines and therapeutics, directly competing with YS Biopharma's biopharmaceutical innovations.
Novavax
NVAX
Mkt Cap1.6B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with YS Biopharma's focus on therapeutic solutions.
Pfizer
PFE
Mkt Cap138.61B
Pfizer Inc. is a large pharmaceutical company with a broad product portfolio that includes biopharmaceuticals, competing in various therapeutic areas with YS Biopharma.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of products that compete with YS Biopharma's biopharmaceutical solutions.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including those in areas where YS Biopharma operates.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and consumer healthcare products, competing with YS Biopharma in the biopharmaceutical field.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is known for its high-quality medicines, vaccines, biologic therapies, and animal health products, competing across several of YS Biopharma's key areas.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, directly competing with YS Biopharma in the development of innovative therapeutic solutions.
Sanofi
SNY
Mkt Cap103.32B
Sanofi operates globally in pharmaceuticals, covering a broad range of therapeutic areas and competing with YS Biopharma in the biopharmaceutical and vaccine sectors.

About

LakeShore Biopharma Co., Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer. A cornerstone of its strategy is the proprietary PIKA immunomodulating technology platform. This innovative platform underpins the development of several key pipeline assets, including a PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. LakeShore Biopharma maintains operations across an international footprint, with a presence in China, the United States, Singapore, the United Arab Emirates, and the Philippines. Established in 2002, the company was initially known as YS Biopharma Co., Ltd. It rebranded to LakeShore Biopharma Co., Ltd in May 2024. The company's corporate headquarters are located in Beijing, China.
Show more...
CEO
Mr. Wang Xu
Employees
758
Country
Cayman Islands
ISIN
KYG9845F2080

Listings

OTC Link
US
LSBWF
US
LSBCF

0 Comments

Share your thoughts

FAQ

What is LakeShore Biopharma stock price today?▼
The current price of LSBCF is $0.07 USD — it has increased by +0% in the past 24 hours. Watch LakeShore Biopharma stock price performance more closely on the chart.
What is LakeShore Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange LakeShore Biopharma stocks are traded under the ticker LSBCF.
What is LakeShore Biopharma market cap?▼
Today LakeShore Biopharma has the market capitalization of 1.39M
What is LakeShore Biopharma revenue for the last year?▼
LakeShore Biopharma revenue for the last year amounts to 158.59M USD.
What is LakeShore Biopharma net income for the last year?▼
LSBCF net income for the last year is -119.88M USD.
How many employees does LakeShore Biopharma have?▼
As of July 12, 2026, the company has 758 employees.
In which sector is LakeShore Biopharma located?▼
LakeShore Biopharma operates in the Other sector.
When did LakeShore Biopharma complete a stock split?▼
LakeShore Biopharma has not had any recent stock splits.
Where is LakeShore Biopharma headquartered?▼
LakeShore Biopharma is headquartered in Beijing, Cayman Islands.